Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Absorbed Dose
26%
Activity Coefficient
43%
Akaike Weights
14%
Bayesian Fitting
9%
Bi-exponential
13%
Biodistribution
11%
Biokinetics
30%
Coefficient of Variation
10%
Dosimetry
12%
DOTATATE
12%
Exponential Function
16%
Exponential Sums
10%
FcRn
12%
Fitting Function
14%
Fitting Method
9%
Global Sensitivity Analysis
9%
Goodness-of-fit
7%
Humanized
9%
Integrated Activities
74%
Kidney
38%
Liver
9%
Lutetium-177 (177Lu)
10%
Mathematical Model
9%
Mathematical Phantoms
13%
Model Selection
37%
Molecular Radiotherapy
20%
Monoclonal IgG Antibodies
10%
Nonlinear Mixed Effects
40%
NONMEM
17%
Pediatric Subjects
9%
Peptide Receptor Radionuclide Therapy
45%
Phantom
9%
Pharmacokinetic Data
9%
Pharmacokinetic Model
9%
Pharmacokinetics
22%
Physiologically-based Pharmacokinetic Model
65%
Point Dosimetry
24%
Population-based Model
16%
PSMA-617
7%
Quantitative Systems Pharmacology
9%
Radiopharmaceuticals
10%
Relative Standard Deviation
22%
Root Mean Square Error
12%
Sampling Schedule
9%
Shared Parameters
8%
Single Time Point
33%
SPECT-CT
7%
Spleen
8%
Treatment Planning
26%
Tumor
17%
Pharmacology, Toxicology and Pharmaceutical Science
Akaike Information Criterion
15%
Biodistribution
25%
Castration Resistant Prostate Cancer
5%
Dosimetry
64%
Gallium 68
5%
Immunoglobulin G Antibody
10%
Indium 111
21%
Iodine-131
9%
Kidney Tumour
9%
Lutetium 177
42%
Meningioma
6%
Model Selection
57%
Monoclonal Antibody
5%
Neoplasm
46%
Neuroendocrine Tumor
6%
Peptide
7%
Pharmacokinetic Parameter
11%
Pharmacokinetics
100%
Physiologically Based Pharmacokinetic Modelling
15%
Polyethylene Terephthalate
20%
Prostate Specific Membrane Antigen
6%
Radioisotope
59%
Receptor
64%
Tetraxetan
10%
Thyroid Disease
9%
Transient Ischemic Attack
12%
Yttrium 90
5%
